Keros Therapeutics, Inc. (KROS) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $4.00K; Additional Paid in CapitalUSD $1.18B; Treasury Stock, Common, ValueUSD $384.56M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $4.00K; Additional Paid in CapitalUSD $1.18B; Treasury Stock, Common, ValueUSD $384.56M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $4.00K; Additional Paid in CapitalUSD $1.17B; Treasury Stock, Common, ValueUSD $384.56M.
- 2025-11-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD (m); Treasury Stock, Common, ValueUSD (m).
Keros Therapeutics, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Common, Value USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock, Shares, Acquired shares | Treasury Stock Acquired, Average Cost Per Share USD/shares | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $4.00K | $1.18B | $384.56M | $-534.18M | $262.32M | 21.13M | (m) | 3 month · $5.38M | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $4.00K | $1.18B | $384.56M | $-505.47M | $285.63M | 21.13M | (m) | 3 month · $6.20M | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $4.00K | $1.17B | $384.56M | $-481.76M | $303.13M | 21.13M | 12 month · $384.56M | 12 month · $28.70M | (m) | (m) | (m) |
| 2025-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · 10.95M | (m) | (m) |
| 2025-10-20 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 10.95M | (m) | (m) |
| 2025-10-15 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 17.75 | (m) |
| 2025-09-30 | $0.00 | $4.00K | $1.16B | (m) | $-458.30M | $703.58M | (m) | (m) | 3 month · $3.99M | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $4.00K | $1.16B | (m) | $-451.02M | $706.73M | (m) | (m) | 3 month · $8.54M | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $4.00K | $1.15B | (m) | $-420.33M | $728.87M | (m) | (m) | 3 month · $8.86M | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $4.00K | $1.14B | $0.00 | $-568.78M | $571.55M | 0.00 | (m) | 12 month · $34.87M | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $4.00K | $1.06B | (m) | $-522.75M | $532.84M | (m) | (m) | 3 month · $8.82M | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $3.00K | $890.71M | (m) | $-469.80M | $420.92M | (m) | (m) | 3 month · $8.79M | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $3.00K | $878.48M | (m) | $-424.54M | $453.95M | (m) | (m) | 3 month · $8.07M | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $3.00K | $713.64M | (m) | $-381.43M | $332.21M | (m) | (m) | 12 month · $28.76M | (m) | (m) | (m) |
| 2023-09-30 | (m) | $3.00K | $637.02M | (m) | $-341.18M | $295.84M | (m) | (m) | 3 month · $8.71M | (m) | (m) | (m) |
| 2023-06-30 | (m) | $3.00K | $628.00M | (m) | $-301.74M | $326.26M | (m) | (m) | 3 month · $7.04M | (m) | (m) | (m) |
| 2023-03-31 | (m) | $3.00K | $619.22M | (m) | $-264.24M | $354.98M | (m) | (m) | 3 month · $5.69M | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $2.00K | $505.86M | (m) | $-228.43M | $277.42M | (m) | (m) | 12 month · $18.68M | (m) | (m) | (m) |
| 2022-09-30 | (m) | $2.00K | $439.74M | (m) | $-198.72M | $241.03M | (m) | (m) | 3 month · $4.75M | (m) | (m) | (m) |
| 2022-06-30 | (m) | $2.00K | $386.41M | (m) | $-175.21M | $211.21M | (m) | (m) | 3 month · $4.79M | (m) | (m) | (m) |
| 2022-03-31 | (m) | $2.00K | $371.43M | (m) | $-147.94M | $223.49M | (m) | (m) | 3 month · $4.39M | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | $2.00K | $366.93M | (m) | $-123.75M | $243.17M | (m) | (m) | 12 month · $11.72M | (m) | (m) | (m) |
| 2021-09-30 | (m) | $2.00K | $335.29M | (m) | $-116.81M | $218.48M | (m) | (m) | 3 month · $3.08M | (m) | (m) | (m) |
| 2021-06-30 | (m) | $2.00K | $332.17M | (m) | $-96.52M | $235.66M | (m) | (m) | 3 month · $2.85M | (m) | (m) | (m) |
| 2021-03-31 | (m) | $2.00K | $329.27M | (m) | $-80.90M | $248.37M | (m) | (m) | 3 month · $2.49M | (m) | (m) | (m) |
| 2020-12-31 | (m) | $2.00K | $326.73M | (m) | $-65.01M | $261.72M | (m) | (m) | 12 month · $4.10M | (m) | (m) | (m) |
| 2020-09-30 | (m) | $2.00K | $185.09M | (m) | $-54.34M | $130.76M | (m) | (m) | 3 month · $1.42M | (m) | (m) | (m) |
| 2020-06-30 | (m) | $2.00K | $183.66M | (m) | $-42.30M | $141.36M | (m) | (m) | 3 month · $1.14M | (m) | (m) | 3 month · $8.00K |
| 2020-03-31 | (m) | $1.00K | $6.67M | (m) | $-31.54M | $-24.87M | (m) | (m) | 3 month · $12.00K | (m) | (m) | (m) |
| 2019-12-31 | (m) | $1.00K | $203.00K | (m) | $-19.65M | $-19.45M | (m) | (m) | 12 month · $59.00K | (m) | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | $-16.72M | (m) | (m) | 3 month · $17.00K | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | $-13.19M | (m) | (m) | 3 month · $13.00K | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | $-10.36M | (m) | (m) | 3 month · $11.00K | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | $-7.18M | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |